| 1 | [SID56424031] | Active | Potency | 0.0259 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.0259 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 2 | [SID56424031] | Active | Potency | 0.0259 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.0259 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID56424031] | Active | Potency | 0.0259 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.0259 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID56424031] | Active | Potency | 0.0731 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.0731 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID56424031] | Active | Potency | 0.0731 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.0731 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID56424031] | Active | Potency | 0.0731 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.0731 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID56424031] | Active | EC50 | 0.1 | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen [AID2252, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | EC50 | 0.1 [uM] | | BioAssay | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen | | AID | 2252 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID103770810] | Active | IC50 | 0.1 | Cytotoxicity against doxorubicin-sensitive human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay [AID632891, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103770810 | | CID | 5458171 | | Outcome | Active | | IC50 | 0.1 [uM] | | BioAssay | Cytotoxicity against doxorubicin-sensitive human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay | | AID | 632891 | | BioAssay type | Literature | | Target | | | PubMed | 22011244 | | Data Table |  |
|
| 9 | [SID103770810] | Active | IC50 | 0.1 | Cytotoxicity against human LoVo cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay [AID632889, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103770810 | | CID | 5458171 | | Outcome | Active | | IC50 | 0.1 [uM] | | BioAssay | Cytotoxicity against human LoVo cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay | | AID | 632889 | | BioAssay type | Literature | | Target | | | PubMed | 22011244 | | Data Table |  |
|
| 10 | [SID85273759] | Active | AC50 | 0.15 | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity [AID652116, Type: confirmatory] | RAD52 gene product [Homo sapiens] [gi:109637798] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 0.15 [uM] | | BioAssay | FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_Dose_CherryPick_Activity | | AID | 652116 | | BioAssay type | confirmatory | | Target | RAD52 gene product [Homo sapiens] [gi:109637798] | | PubMed | | | Data Table |  |
|
| 11 | [SID85273759] | Active | AC50 | 0.535 | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity [AID624134, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 0.535 [uM] | | BioAssay | Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity | | AID | 624134 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID85273759] | Active | AC50 | 0.658 | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity [AID624132, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 0.658 [uM] | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624132 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID56424031] | Active | Potency | 0.8275 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.8275 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID103770810] | Active | IC50 | 0.9 | Cytotoxicity against human LoVo cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay [AID632890, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103770810 | | CID | 5458171 | | Outcome | Active | | IC50 | 0.9 [uM] | | BioAssay | Cytotoxicity against human LoVo cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay | | AID | 632890 | | BioAssay type | Literature | | Target | | | PubMed | 22011244 | | Data Table |  |
|
| 15 | [SID56424031] | Active | Potency | 0.9285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.9285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID56424031] | Active | Potency | 0.9466 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 0.9466 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 17 | [SID103770810] | Active | IC50 | 1 | Cytotoxicity against doxorubicin-sensitive human MCF7 cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay [AID632892, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103770810 | | CID | 5458171 | | Outcome | Active | | IC50 | 1 [uM] | | BioAssay | Cytotoxicity against doxorubicin-sensitive human MCF7 cells under hypoxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay | | AID | 632892 | | BioAssay type | Literature | | Target | | | PubMed | 22011244 | | Data Table |  |
|
| 18 | [SID85273759] | Active | IC50 | 1.101 | Discovery of Small Molecule Probes for H1N1 Influenza NS1A [AID504329, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | IC50 | 1.101 [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 Influenza NS1A | | AID | 504329 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] | | PubMed | | | Data Table |  |
|
| 19 | [SID56424031] | Active | Potency | 1.122 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 1.122 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 20 | [SID56424031] | Active | Potency | 1.122 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 1.122 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 21 | [SID56424031] | Active | Potency | 1.122 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 1.122 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID85273759] | Active | AC50 | 1.336 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 1.336 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 23 | [SID85273759] | Active | AC50 | 1.362 | 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity [AID504726, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 1.362 [uM] | | BioAssay | 24 hour HeLa Cytotox assay Measured in Cell-Based System Using Plate Reader - 2117-03_Inhibitor_Dose_CherryPick_Activity | | AID | 504726 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 24 | [SID56424031] | Active | Potency | 1.4125 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 1.4125 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 25 | [SID56424031] | Active | Potency | 1.4581 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 1.4581 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 26 | [SID56424031] | Active | Potency | 1.4581 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 1.4581 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 27 | [SID56424031] | Active | Potency | 1.4581 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 1.4581 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 28 | [SID85273759] | Active | AC50 | 1.48 | RAD52: DNA binders Measured in Biochemical System Using Plate Reader - 7018-02_Inhibitor_Dose_CherryPick_Activity [AID652128, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 1.48 [uM] | | BioAssay | RAD52: DNA binders Measured in Biochemical System Using Plate Reader - 7018-02_Inhibitor_Dose_CherryPick_Activity | | AID | 652128 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID56424031] | Active | IC50 | 2.23 | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay [AID489035, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | IC50 | 2.23 [uM] | | BioAssay | Dose response confirmation of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay | | AID | 489035 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID56424031] | Active | Potency | 2.3109 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 2.3109 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID56424031] | Active | IC50 | 4.2 | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489033, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | IC50 | 4.2 [uM] | | BioAssay | Dose Response selectivity of uHTS chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489033 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID103770810] | Active | IC50 | 4.5 | Displacement of ethidium bromide from DNA by fluorometric analysis [AID632887, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103770810 | | CID | 5458171 | | Outcome | Active | | IC50 | 4.5 [uM] | | BioAssay | Displacement of ethidium bromide from DNA by fluorometric analysis | | AID | 632887 | | BioAssay type | Literature | | Target | | | PubMed | 22011244 | | Data Table |  |
|
| 33 | [SID56424031] | Active | EC50 | 4.688 | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction [AID435023, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | EC50 | 4.688 [uM] | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 435023 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 34 | [SID103770810] | Active | IC50 | 4.7 | Cytotoxicity against doxorubicin-resistant human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay [AID632893, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103770810 | | CID | 5458171 | | Outcome | Active | | IC50 | 4.7 [uM] | | BioAssay | Cytotoxicity against doxorubicin-resistant human MCF7 cells under oxic condition assessed as growth inhibition after 74 hrs by sulforhodamine B assay | | AID | 632893 | | BioAssay type | Literature | | Target | | | PubMed | 22011244 | | Data Table |  |
|
| 35 | [SID56424031] | Active | Potency | 5.0119 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 36 | [SID85273759] | Active | CC50 | 5.121 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity [AID624300, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | CC50 | 5.121 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity | | AID | 624300 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID56424031] | Active | EC50 | 5.25 | Confirmation dose response of hits from high-throughput yeast screen for caloric restriction mimetics that inhibit age-related superoxide [AID449753, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | EC50 | 5.25 [uM] | | BioAssay | Confirmation dose response of hits from high-throughput yeast screen for caloric restriction mimetics that inhibit age-related superoxide | | AID | 449753 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID56424031] | Active | EC50 | 5.882 | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2821, Type: confirmatory] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | EC50 | 5.882 [uM] | | BioAssay | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2821 | | BioAssay type | confirmatory | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 39 | [SID56424031] | Active | EC50 | 5.882 | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2821, Type: confirmatory] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | EC50 | 5.882 [uM] | | BioAssay | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2821 | | BioAssay type | confirmatory | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 40 | [SID56424031] | Active | EC50 | 5.882 | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity [AID2821, Type: confirmatory] | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | EC50 | 5.882 [uM] | | BioAssay | Luminescence Cell-Free Homogenous Dose Retest to Identify Inhibitors of Serine/Threonine Kinase 33 Activity | | AID | 2821 | | BioAssay type | confirmatory | | Target | serine/threonine-protein kinase 33 [Homo sapiens] [gi:23943882] | | PubMed | | | Data Table |  |
|
| 41 | [SID56424031] | Active | EC50 | 6.58 | Confirmation dose response of additional hit compounds from high-throughput yeast screen for caloric restriction mimetics that inhibit age-related superoxide. [AID504927, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | EC50 | 6.58 [uM] | | BioAssay | Confirmation dose response of additional hit compounds from high-throughput yeast screen for caloric restriction mimetics that inhibit age-related superoxide. | | AID | 504927 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID56424031] | Active | Potency | 7.9433 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 43 | [SID56424031] | Active | Potency | 8.9125 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 44 | [SID56424031] | Active | Potency | 8.9125 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 45 | [SID56424031] | Active | Potency | 8.9125 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 46 | [SID56424031] | Active | Potency | 8.9125 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 47 | [SID85273759] | Active | AC50 | 9.515 | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity [AID588345, Type: confirmatory] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 9.515 [uM] | | BioAssay | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588345 | | BioAssay type | confirmatory | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 48 | [SID85273759] | Active | AC50 | 9.515 | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity [AID588345, Type: confirmatory] | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85273759 | | CID | 5458171 | | Outcome | Active | | AC50 | 9.515 [uM] | | BioAssay | MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588345 | | BioAssay type | confirmatory | | Target | dual specificity tyrosine-phosphorylation-regulated kinase 1A [Rattus norvegicus] [gi:6978787] | | PubMed | | | Data Table |  |
|
| 49 | [SID56424031] | Active | Potency | 10 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 50 | [SID56424031] | Active | Potency | 10.6213 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56424031 | | CID | 5458171 | | Outcome | Active | | Potency | 10.6213 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|